Literature DB >> 19813207

Muscle strength and fatigue in patients with generalized myasthenia gravis.

Caitlin J Symonette1, Bradley V Watson, Wilma J Koopman, Michael W Nicolle, Timothy J Doherty.   

Abstract

Myasthenia gravis (MG) is characterized by fatigue and fluctuating muscle weakness resulting from impaired neuromuscular transmission (NMT). The objective of this study was to quantify, by direct measurement of muscle force, the strength and fatigue of patients with MG. A maximal voluntary isometric contraction protocol of shoulder abductors was used in conjunction with conventional fatigue and disease-severity instruments. Results from patients with (D-MG) and without (ND-MG) decrement on repetitive nerve stimulation (RNS) of the spinal accessory and axillary nerves were compared with healthy controls. Patients with MG reported greater fatigue than controls. Muscle strength was lowest in the D-MG group, followed by the ND-MG group and controls. Normalized shoulder abduction fatigue and recovery values did not differ between the D-MG and ND-MG groups or controls. The RNS decrement appears to relate best to disease severity and muscle weakness but not to objective measures of fatigue in this population.

Entities:  

Mesh:

Year:  2010        PMID: 19813207     DOI: 10.1002/mus.21493

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  9 in total

1.  Fatigue in patients with myasthenia gravis.

Authors:  T M Alekseeva; Y V Gavrilov; O A Kreis; P O Valko; K P Weber; Y Valko
Journal:  J Neurol       Date:  2018-08-11       Impact factor: 4.849

Review 2.  Pain, Headache, and Other Non-motor Symptoms in Myasthenia Gravis.

Authors:  Olivia Tong; Leslie Delfiner; Steven Herskovitz
Journal:  Curr Pain Headache Rep       Date:  2018-05-03

3.  Extracorporeal immunoglobulin elimination for the treatment of severe myasthenia gravis.

Authors:  M Blaha; J Pit'ha; V Blaha; M Lanska; J Maly; S Filip; H Langrova
Journal:  J Biomed Biotechnol       Date:  2010-03-15

Review 4.  Fatigue as a symptom or comorbidity of neurological diseases.

Authors:  Iris-Katharina Penner; Friedemann Paul
Journal:  Nat Rev Neurol       Date:  2017-10-13       Impact factor: 42.937

5.  Does cardiovascular autonomic dysfunction contribute to fatigue in myasthenia gravis?

Authors:  A Elsais; E Kerty; K Russell; K Toska
Journal:  Physiol Res       Date:  2022-01-19       Impact factor: 1.881

6.  Effect of Gender, Disease Duration and Treatment on Muscle Strength in Myasthenia Gravis.

Authors:  Gülsenay Citirak; Sanja Cejvanovic; Henning Andersen; John Vissing
Journal:  PLoS One       Date:  2016-10-14       Impact factor: 3.240

7.  Eculizumab improves fatigue in refractory generalized myasthenia gravis.

Authors:  Henning Andersen; Renato Mantegazza; Jing Jing Wang; Fanny O'Brien; Kaushik Patra; James F Howard
Journal:  Qual Life Res       Date:  2019-03-23       Impact factor: 4.147

8.  Fatigue in myasthenia gravis: is it more than muscular weakness?

Authors:  Ahmed Elsais; Vegard B Wyller; Jon Håvard Loge; Emilia Kerty
Journal:  BMC Neurol       Date:  2013-10-03       Impact factor: 2.474

9.  A continuous repetitive task to detect fatigability in spinal muscular atrophy.

Authors:  Marloes Stam; Renske I Wadman; Bart Bartels; Maureen Leeuw; Henk-Jan Westeneng; Camiel A Wijngaarde; Leonard H van den Berg; W Ludo van der Pol
Journal:  Orphanet J Rare Dis       Date:  2018-09-12       Impact factor: 4.123

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.